Pneumococcal carriage in United Kingdom families: Estimating serotype-specific transmission parameters from longitudinal data

American Journal of Epidemiology

Volumn 166, Issue 2, 2007, Pages 228-235

  Melegaro, Alessia ^a   Choi, Yoon ^a   Pebody, Richard ^a   Gay, Nigel ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Disease transmission; Longitudinal studies; Models, statistical; Pneumococcal infections; Pneumonia, pneumococcal; Streptococcus pneumoniae

Indexed keywords

BACTERIUM; DISEASE TRANSMISSION; MARKOV CHAIN;

ARTICLE; DATA ANALYSIS; DISEASE CARRIER; DISEASE TRANSMISSION; FAMILY STUDY; HOUSEHOLD; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; PRESCHOOL CHILD; PROBABILITY; SEROTYPE; STATISTICAL MODEL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; ADULT; CLASSIFICATION; FAMILY; HETEROZYGOTE; PNEUMONIA; SEROTYPING; STATISTICS;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

STREPTOCOCCUS PNEUMONIAE;

ADULT; CARRIER STATE; CHILD, PRESCHOOL; DISEASE TRANSMISSION; FAMILY; GREAT BRITAIN; HUMANS; LONGITUDINAL STUDIES; MARKOV CHAINS; PNEUMONIA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 34547564147     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm076     Document Type: Article

References (48)

1. Fedson DS, Scott JA, Scott G. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 1999;17:S11-18.
2. Robinson K, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. Opportunities for prevention in the conjugate vaccine era. JAMA 2001;285:1729-35.
3. Cartwright K. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr 2002;161:188-95.
4. Pebody RG, Hellenbrand W, D'Ancona F, et al. Pneumococcal disease surveillance in Europe. Euro Surveill 2006;11:171-8.
5. Johnston RB Jr. Pathogenesis of pneumococcal pneumonia. Rev Infect Dis 1991;13(suppl 6):S509-17.
6. Booy R, Heath P, Willocks L, et al. Invasive pneumococcal infections in children. Lancet 1995;345:1245-6.
7. Miller E, Waight P, Efstratiou A, et al. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl 2000;435:11-16.
8. Schuchat A, Dowell SF. Pneumonia in children in the developing world: new challenges, new solutions. Semin Pediatr Infect Dis 2004;15:181-9.
9. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002;185:927-36.
10. Obaro SK, Adegbola RA, Banya WA, et al. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996;348:271-2.
11. Huang SS, Platt R, Rifas-Shiman SL, et al. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005;116:e408-13.
12. Hennessy TW, Singleton RJ, Bulkow LR, et al. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine 2005;23:5464-73.
13. Hammitt LL, Bruden DL, Butler JC, et al. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 2006;193:1487-94.
14. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
15. Gonzalez BE, Hulten KG, Lamberth L, et al. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 2006;25:301-5.
16. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003;361:2189-95.
17. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46.
18. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004;113:443-9.
19. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005;54:893-7.
20. Melegaro A, Gay NJ, Medley GF. Estimating the transmission parameters of pneumococcal carriage in household. Epidemiol Infect 2004;132:433-41.
21. Hussain M, Melegaro A, Pebody RG, et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 2005;133:891-8.
22. O'Brien KL, Nohynek H. Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J 2003;22:133-40.
23. Diggle P, Heagerty P, Liang K, et al. Analysis of longitudinal data. New York, NY: Oxford University Press, 1994.
24. Anderson R, May R. Infectious diseases of humans. Oxford, United Kingdom: Oxford University Press, 1991.
25. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A 1997;94:6571-6.
26. Williams B, Dye C. Maximum likelihood for parasitologists. Parasitol Today 1994;10:489-93.
27. Hilborn R, Mangel M. The ecological detective. Confronting models with data. Princeton, NJ: Princeton University Press, 1997.
28. Brown D, Rothery P. Advanced model fitting. Models in biology: mathematics, statistics and computing. Chichester, United Kingdom: Wiley, 1993.
29. Armitage P, Colton T. Encyclopedia of biostatistics. 2nd ed. Chichester, United Kingdom: John Wiley & Sons, 2004.
30. Akaike H. A new look at the statistical model identification. IEEE Transact Automat Control 1974;19:716-23.
31. Smith T, Lehmann D, Montgomery J, et al. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993;111:27-39.
32. Brueggemann AB, Griffiths DT, Meats E, et al. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003;187:1424-32.
33. Ekdahl K, Ahlinder I, Hansson HB, et al. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Clin Infect Dis 1997;25:1113-17.
34. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999;5:336-45.
35. Lipsitch M, Dykes JK, Johnson SE, et al. Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine 2000;18:2895-901.
36. Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotypespecific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 2006;194:682-8.
37. Gray B, Converse G, Dillon H. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
38. Auranen K, Arjas E, Leino T, et al. Transmission of pneumococcal carriage in families: a latent Markov Process Model for binary longitudinal data. J Am Stat Assoc 2000;95:1044-53.
39. Cauchemez S, Temime L, Valleron AJ, et al. S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools. BMC Infect Dis 2006;6:14.
40. Dietz K. Epidemiologic interference of virus populations. J Math Biol 1979;8:291-300.
41. Elveback L, Fox J, Varma A. An extension of the Reed-Frost epidemic model for the study of competition between viral agents in the presence of interference. Am J Hyg 1964;80:356-64.
42. Elveback LR, Ackerman E, Young G, et al. A stochastic model for competition between viral agents in the presence of interference. 1. Live virus vaccine in a randomly mixing population, Model 3. Am J Epidemiol 1968;87:373-84.
43. Gupta S, Swinton J, Anderson RM. Theoretical studies of the effects of heterogeneity in the parasite population on the transmission dynamics of malaria. Proc R Soc Lond B Biol Sci 1994;256:231-8.
44. May RM, Nowak MA. Superinfection, metapopulation dynamics, and the evolution of diversity. J Theor Biol 1994; 170:95-114.
45. Nowak MA, May RM. Superinfection and the evolution of parasite virulence. Proc R Soc Lond B Biol Sci 1994;255:81-9.
46. Gupta S, Trenholme K, Anderson RM, et al. Antigenic diversity and the transmission dynamics of Plasmodium falciparum. Science 1994;263:961-3.
47. White LJ, Cox MJ, Medley GF. Cross immunity and vaccination against multiple microparasite strains. J Math Appl Med Biol 1998;15:211-33.
48. Gomes MG, Medley GF, Nokes DJ. On the determinants of population structure in antigenically diverse pathogens. Proc R Soc Lond B Biol Sci 2002;269:227-33.